Skip to main content

Advertisement

Table 3 Baseline of demographic and clinical characteristics of patients during the trial

From: Effects of Spirulina platensis supplementation on lipid profile in HIV–infected antiretroviral naïve patients in Yaounde - Cameroon: a randomized trial study

Variables Ctrl/Spi Period Patients received local balance diet Patients received spirulina combined with a local balance diet p-value
Age (Years) 87/82 T0 35.43 ± 10.04 36.01 ± 9.44 0,58
Sex (%)      
Female 87/82 T0 64.5% (56) 69.8% (60) 0.06
Male 35.6% (31) 25.6% (22)
BMI (kg/m 2 ) 87/82 T0 26.02 ± 4.97 25.29 ± 4.54 0.33
79/80 T6 25.18 ± 6.41 25.41 ± 4.98 0.80
66/79 T12 22.18 ± 1.07 23.26 ± 6.53 0.44
Fasting blood sugar (mg/l) 87/82 T0 115 ± 53,70 105.89 ± 25.91 0.159
79/80 T6 105.00 ± 30.76 103.14 ± 15.93 0.65
66/79 T12 113.77 ± 61,85 95.35 ± 9.63 <0,001
Alcohol 14/169 To 11.9% 11.9%  
  10/156 T6 11.9% 5.6%  
  7/145 T12 4.4% 4.4%  
Smoking 5/169 To 3% 4.5%  
  5/169 T6 3% 4.5%  
  6/169 T12 1.4% 3%  
  1. Ctrl: Control, Spi: Spirulina group, T0: initial period, T6: Six months, T12: Twelve months, p< 0.01: Significant difference between the group.